Swedish Orphan Biovitrum: EU Grants Marketing Authorisation For ALTUVOCT To Treat Haemophilia A
19/6 08:59
(RTTNews) - Swedish Orphan Biovitrum AB or Sobi (BIOVF.PK) announced Wednesday that the European Commission has granted Marketing Authorisation for ALTUVOCT (efanesoctocog alfa), to treat and prevent bleeds and perioperative prophylaxis in haemophilia A....